Skip to main content

Day: May 17, 2022

Fanhua to Announce First Quarter 2022 Unaudited Financial Results and Host Conference Call on May 26, 2022

Written by Customer Service on . Posted in Public Companies.

GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) — Fanhua Inc. (“Fanhua” or “the Company”) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it will release its unaudited financial results for first quarter 2022 after the close of the U.S. financial markets on May 26, 2022. Mr. Yinan Hu, chairman and CEO and Mr. Peng Ge, CFO will host a conference call to discuss first quarter 2022 financial results at: Time: 9:00 p.m. Eastern Time on May 26, 2022    or 9:00 a.m. Beijing Time on May 27, 2022 The toll free dial-in numbers:United States 1-833-239-5565Hong Kong, China 800-906-601South Korea 080-850-0474The toll dial-in numbers:China (Mainland) 400-820-5286Hong Kong, China & Other Areas +852 30-186-771United Kingdom +44 203-692-8125Conference ID #: 4067079 Additionally,...

Continue reading

CORRECTING AND REPLACING: Definitive Healthcare to Present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference

Written by Customer Service on . Posted in Public Companies.

FRAMINGHAM, Mass., May 16, 2022 (GLOBE NEWSWIRE) — In a previous version of this release issued earlier today by Definitive Healthcare Corp. (Nasdaq: DH), the date of the presentation was Monday, May 23, 2022 at 9:20 a.m. ET. The correct presentation date is Wednesday, May 25th at 10:00 a.m. ET. The updated release reads:  Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Chief Executive Officer, Jason Krantz, and its Chief Financial Officer, Rick Booth, will present at the J.P. Morgan 50th Annual Global Technology, Media and Communications Conference. The Definitive Healthcare presentation is scheduled for Wednesday, May 25, 2022, at 10:00 a.m. Eastern Time. A live webcast of the presentation will be available on the...

Continue reading

Mydecine Announces First Quarter 2022 Financial Results and Highlights

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

DENVER, May 16, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results and provided a business update for the first quarter of 2022.  “Our team had an extremely productive first quarter,” said Mydecine CEO Josh Bartch. “Management has been working diligently to decrease expenses and increase efficiencies, setting Mydecine up for future success. On the heels of Mydecine’s positive pre-Investigational New Drug Application (“IND”) meeting with the FDA and a conditional Institutional Review Board (“IRB”) approval, we are excited, and working towards submitting our full IND and breakthrough therapy applications...

Continue reading

WaveDancer Releases First Quarter 2022 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Investments In Transformation Continue-Expected to Begin Driving Revenue Growth in 2Q 2022 FAIRFAX, Va., May 16, 2022 (GLOBE NEWSWIRE) — WaveDancer (NASDAQ: WAVD), today reported its results for the first quarter ended March 31, 2022, which was characterized by continued investment in the WaveDancer’s software development and sales team. This included new hires, board appointments, partnerships, and a definitive acquisition agreement as WaveDancer strives to become a leader in the zero trust, blockchain, and secure supply chain market. WaveDancer CEO Jamie Benoit commented, “Our first quarter 2022 saw the company continue to prioritize investments in key operational areas.   In addition to the recent additions, we have made at the board and senior leadership levels, we have also added three new blockchain sales professionals as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.